Not yet recruitingPhase 2NCT07447076

Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)

Studying Atypical teratoid rhabdoid tumor

Last synced from ClinicalTrials.gov May 4, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sabine Mueller, MD, PhD
Principal Investigator: Sabine Mueller, MD, PhD
University of California, San Francisco
Intervention: Lumber Puncture(procedure)
Enrollment: 29 enrolled
Eligibility: 1-39 years · All sexes
Timeline: 2026 – 2036

Study locations (1)

University of California, San Francisco, San Francisco, California, United States

Collaborators

Pacific Pediatric Neuro-Oncology Consortium · Rally Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07447076 on ClinicalTrials.gov

Other trials for Atypical teratoid rhabdoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Atypical teratoid rhabdoid tumor →

← Back to all trials